Monoclonal Anti-polyHistidine-Peroxidase antibody produced in mouse, clone HIS-1, purified immunoglobulin, lyophilized powder

Code: a7058-1vl D2-231

Not available outside of the UK & Ireland.

Application

Antibody suitable for immunoblotting. Working dilution 1:2000Also suitable for dot blot assays and ELISA

General description

The mono...


read more

Your Price
$461.10 EACH
$553.32 inc. VAT

Not available outside of the UK & Ireland.

Application

Antibody suitable for immunoblotting. Working dilution 1:2000Also suitable for dot blot assays and ELISA

General description

The monoclonal anti-polyHistidine Peroxidase Conjugate antibody recognizes native and denatured forms of synthetic polyhistidine or polyhistidine-tagged fusion proteins. The product is reactive with fusion proteins expressed by prokaryotic pET, pRSET and pTrc expression vectors.

Immunogen

recombinant polyHistidine tagged fusion protein.

Legal Information

This Product is covered by patent DE 19507166 and foreign equivalents exclusively licensed to QIAGEN GmbH, Qiagen Strasse 1, D-40724 Hilden, Germany.

Physical form

Lyophilized from 0.01 M phosphate buffered saline, pH 7.4, containing 1% bovine serum albumin and 0.05% MIT.

Preparation Note

Prepared by the two-step glutaraldehyde method described by Avrameas, S., et al., Scand. J. Immunol., 8, Suppl. 7, 7 (1978).

Reconstitution

The antibody conjugate should be reconstituted with 0.5 ml deionized water.

Specificity

The antibody recognizes synthetic polyHistidine, as well as native or denatured, reduced forms of proteins tagged with 6X histidines, expressed in selected vectors.

antibody formpurified from hybridoma cell culture
antibody product typeprimary antibodies
biological sourcemouse
cloneHIS-1, monoclonal
concentration5-11 mg/mL
conjugateperoxidase conjugate
formlyophilized powder
isotypeIgG2a
packagingvial of 0.5 mL
Quality Level200
storage temp.2-8°C
technique(s)western blot: 1:2,000 using lysates of Escherichia coli induced to express a 6xHis tagged protein
This product has met the following criteria: